Consolidated Statements of Shareholders Equity (Deficit) - USD ($) $ in Thousands	Series A Common Stock	Series A	Series B Common Stock	Series B	Additional Paid-in Capital	Accumulated Deficit	Accumulated other comprehensive income	Noncontrolling interests	Total
Balance at Jul. 31, 2021	$ 8		$ 169		$ 159,136	$ (40,799)	$ 3,772	$ 14,418	$ 136,704
Balance (in Shares) at Jul. 31, 2021	787,163		16,936,864
Net loss						(124,658)		(17,719)	(142,377)
Stock-based compensation			$ 16		18,045				18,061
Stock-based compensation (in Shares)			1,533,311
Forfeiture of restricted stock			$ (9)		(18,969)				(18,978)
Forfeiture of restricted stock (in Shares)			(943,305)
Common stock sold to investors			$ 28		99,142				99,170
Common stock sold to investors (in Shares)			2,833,425
Transaction costs incurred in connection with sale of common stock					(6,228)				(6,228)
Common stock sold to related party			$ 33		10,964				10,997
Common stock sold to related party (in Shares)			3,338,307
Shares withheld for payroll taxes					(75)				(75)
Shares withheld for payroll taxes (in Shares)			(10,638)
Unrealized loss on available-for-sale securities							(63)		(63)
Acquisition of additional ownership interest in LipoMedix					8			(8)
Foreign currency translation adjustment							(5)		(5)
Balance at Jul. 31, 2022	$ 8		$ 237		262,023	(165,457)	3,704	(3,309)	97,206
Balance (in Shares) at Jul. 31, 2022	787,163	787,163	23,687,964	23,687,964
Net loss						(1,876)		(339)	(2,215)
Stock-based compensation			$ 2		3,089				3,091
Stock-based compensation (in Shares)			220,019
Forfeiture of restricted stock			$ (2)		(901)				(903)
Forfeiture of restricted stock (in Shares)			(296,759)
Shares withheld for payroll taxes			$ (1)		(217)				(218)
Shares withheld for payroll taxes (in Shares)			(120,697)
Unrealized loss on available-for-sale securities							(290)		(290)
Acquisition of additional ownership interest in LipoMedix					16			(16)
Foreign currency translation adjustment							(42)		(42)
Balance at Jul. 31, 2023	$ 8		$ 236		$ 264,010	$ (167,333)	$ 3,372	$ (3,664)	$ 96,629
Balance (in Shares) at Jul. 31, 2023	787,163	787,163	23,490,527	23,490,527